SVB Securities returns to Leerink Partners name following $100M buyout


A deal between SVB Financial Group and two Boston biotech investing giants to sell its investment banking division, SVB Securities, has been approved, the company announced Thursday.

Previous Strand Associates moves to Chipotle-anchored Arena District building
Next Gilead wins trial over moves to delay generic version of HIV drugs